Lansdale, PA, United States of America

Deborah DeFeo-Jones

USPTO Granted Patents = 6 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 307(Granted Patents)


Location History:

  • Rahway, NJ (US) (2000)
  • Lansdale, PA (US) (1997 - 2001)

Company Filing History:


Years Active: 1997-2001

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Deborah DeFeo-Jones

Introduction

Deborah DeFeo-Jones is a prominent inventor based in Lansdale, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of benign prostatic hyperplasia. With a total of 6 patents to her name, her work has had a substantial impact on medical science.

Latest Patents

Her latest patents include novel pharmaceutical compositions that are useful for the treatment of benign prostatic hyperplasia. These compositions comprise innovative oligopeptides that are selectively cleaved by enzymatically active prostate-specific antigen (PSA), in conjunction with a cytotoxic agent. Additionally, she has developed methods for treating benign prostate hypertrophy, which involve peptides that consist of amino acid sequences recognized and cleaved by free PSA. Her patents also describe assays that utilize these oligopeptides to determine free PSA protease activity both in vitro and in vivo.

Career Highlights

Deborah DeFeo-Jones is currently associated with Merck & Company, Inc., where she continues to advance her research and innovations. Her work has been instrumental in developing therapeutic agents that combine oligopeptides with known cytotoxic agents, showcasing her expertise in the pharmaceutical field.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Victor M. Garsky and Raymond E. Jones. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Deborah DeFeo-Jones exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to the treatment of benign prostatic hyperplasia highlight her dedication to improving medical outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…